Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 3,768 | 3,765 | 3,412 | 3,778 | 3,665 |
| Revenue growth | 0.1% | 10.3% | -9.7% | 3.1% | |
| Cost of goods sold | 1,518 | 1,462 | 1,257 | 1,382 | 1,327 |
| Gross profit | 2,250 | 2,303 | 2,155 | 2,396 | 2,338 |
| Gross margin | 59.7% | 61.2% | 63.2% | 63.4% | 63.8% |
| Selling, general and administrative | 1,478 | 1,389 | 1,253 | 673 | 609 |
| Research and development | 307 | 271 | 253 | 258 | 221 |
| EBITA | 452 | 626 | 611 | 744 | 793 |
| EBITA margin | 12.0% | 16.6% | 17.9% | 19.7% | 21.6% |
| Amortization of intangibles | 244 | 292 | 323 | 348 | 377 |
| EBIT | 208 | 334 | 288 | 396 | 416 |
| EBIT margin | 5.5% | 8.9% | 8.4% | 10.5% | 11.4% |
| Pre-tax income | 73 | 318 | 290 | 399 | 417 |
| Income taxes | 58 | 125 | 307 | 96 | -302 |
| Tax rate | 79.5% | 39.3% | 105.9% | 24.1% | |
| Net income | 6 | 182 | -18 | 303 | 719 |
| Net margin | 0.2% | 4.8% | -0.5% | 8.0% | 19.6% |
| |
| Diluted EPS | $0.02 | $0.52 | ($0.05) | | |
| Shares outstanding (diluted) | 350 | 350 | 350 | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|